Authors: Kolmioviridae
Jens H. Kuhn
Integrated Research Facility at Fort Detrick
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Fort Detrick
Frederick
Maryland 21702
USA
Email: kuhnjens@mail.nih.gov
Artem Babaian
Donnelly Centre and Department of Molecular Genetics
University of Toronto
Toronto
Canada
E-mail: artem.babaian@gmail.com
Laura M. Bergner
MRC-University of Glasgow Centre for Virus Research
Glasgow
UK
E-mail: Laura.Bergner@glasgow.ac.uk
Paul Dény
Department of Clinical Microbiology
Avicenne Hospital
Assistance Publique Hôpitaux de Paris
UFR Santé Médecine Biologie Humaine
University Sorbonne Paris Nord
Bobigny
France
E-mail: paul.deny@inserm.fr
Dieter Glebe
Institute of Medical Virology
National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses
German Center for Infection Research
Justus Liebig University Gießen
Gießen
Germany
E-mail: Dieter.Glebe@viro.med.uni-giessen.de
Masayuki Horie (堀江真行)
Graduate School of Veterinary Science
Osaka Metropolitan University
Izumisano
Osaka
Japan
E-mail: mhorie@omu.ac.jp
Eugene V. Koonin
National Center for Biotechnology Information
National Library of Medicine
National Institutes of Health
Bethesda
Maryland
USA
E-mail: koonin@ncbi.nlm.nih.gov
Mart Krupovic
Institut Pasteur
Université Paris Cité
Archaeal Virology Unit
Paris
France
E-mail: mart.krupovic@pasteur.fr
Sofia Paraskevopoulou (Σοφία Παρασκευοπούλου)
Genome Competence Center (MF1)
Robert Koch Institute
Berlin
Germany
E-mail: ParaskevopoulouS@rki.de
Marcos de la Peña
Instituto de Biología Molecular y Celular de Plantas
Universidad Politécnica de Valencia-CSIC
Valencia
Spain
E-mail: rivero@ibmcp.upv.es
Teemu Smura
University of Helsinki
Medical Faculty
Medicum, Department of Virology
Helsinki
Finland
E-mail: teemu.smura@helsinki.fi
Jussi Hepojoki*
Chair, Ribozyviria Study Group
University of Helsinki
Medical Faculty
Medicum, Department of Virology
Helsinki
Finland
E-mails: jussi.hepojoki@helsinki.fi and jussi.hepojoki@uzh.ch
* corresponding author
A previous version of this Report limited to the genus Deltavirus was contributed by Magnius, L., Taylor, J., Mason, W.S., Sureau, C., Dény, P., and Norder, H.B.
The chapter in the Ninth ICTV Report, which served as the template for the Deltavirus chapter, was contributed by Mason, W.S., Gerlich, W.H., Taylor, J.M., Kann, M., Mizokami, M., Loeb, D., Sureau, C., Magnius, L. and Norder, H.
Acknowledgments
The authors thank Anya Crane and Jiro Wada (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA) for critically editing the text and preparing figures.
Disclaimer
This work was supported in part through Laulima Government Solutions, LLC’s prime contract with the U.S. National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272201800013C. J.H.K. performed this work as an employee of Tunnell Government Services (TGS), a subcontractor of Laulima Government Solutions, LLC, under Contract No. HHSN272201800013C. The content of this publication should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Health and Human Services, or of the institutions and companies affiliated with the authors, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.